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Abstract  1 
BACKGROUND: Agaricus bisporus mushrooms were able to lower cholesterol levels in 2 
hypercholesterolemic rats and it was suggested that dietary fibers might inhibit cholesterol 3 
absorption. However, A. bisporus extracts were also able to inhibit the 4 
3-hydroxy-3-methyl-glutaryl CoA reductase (HMGCR, the key enzyme in the cholesterol 5 
biosynthetic pathway) and this might also contribute to the observed lowering of 6 
cholesterol levels in serum.  7 
RESULTS: The methanol:water extracts obtained from A. bisporus were able to inhibit up 8 
to 60% the HMGCR activity using an in vitro assay. The HMGCR inhibitory capacities 9 
depended on cultivation conditions, strains, etc. The potential inhibitors were not statins, 10 
they might be β-glucans able to scavenge the substrate and impair the enzymatic reaction. 11 
They were present during all mushroom developmental stages and similarly distributed 12 
through all the tissues including the parts discarded as a by-product. Accelerated solvent 13 
extractions using 1:1 ethanol:water as pressurized solvent (10.7 MPa, 25ºC, 5 cycles of 5 14 
min) were more effective in the extraction of the HMGCiR inhibitor/s than supercritical 15 
fluid extractions (9 MPa, 40ºC) using CO2 with 10% ethanol.  16 
CONCLUSION: A mushroom cultivation and two extraction procedures were optimized to 17 
obtain fractions from A. bisporus with high HMGCR inhibitory activities to design novel 18 
ingredients for hypocholesterolemic functional foodstuffs.  19 
 20 
 21 
 22 
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INTRODUCTION 1 
High cholesterol or LDL (low-density lipoprotein) levels in serum increases the risk of 2 
cardiovascular diseases (CVDs).  In public health terms, achieving a reduction in 3 
cholesterol by dietary advice (increase consumption of vegetable and fruits) is of limited 4 
effectiveness.1 Many researchers have been exploring the possibility of increasing 5 
components in foodstuff which have hypocholesterolemic effects such as i.e. β-glucans or 6 
phytosterols.2,3 These novel functionalized foods reduce serum cholesterol (10 – 20%) 7 
because they impair the absorption of exogenous cholesterol during digestion.2,4 However, 8 
depending on genetic variations, many consumers cannot reduce their cholesterol levels 9 
because by avoiding cholesterol intake their 3-hydroxy-3-methyl-glutaryl CoA reductase 10 
(HMGCR) activity is stimulated enhancing the biosynthesis of endogenous cholesterol.5  11 
Thus, another approach to design novel hypocholesterolemic functional foods might be their 12 
supplementation with compounds able to inhibit the HMGCR activity.    13 
Edible mushrooms were able to lower cholesterol levels in vivo (Pleurotus spp., Lentinula 14 
edodes, Ganoderma lucidum, Agaricus bisporus etc.)6-8 and were also able to inhibit the 15 
HMGCR in vitro. Some reports pointed lovastatin as the compound responsible for the enzyme 16 
inhibition.9-11 Lovastatin (mevinolin) and other statins are drugs usually prescribed to 17 
hypercholesterolemic patients because they act as competitive inhibitors of the HMGCR 18 
showing approx 200 folds more affinity for them than their real substrate.12 Moreover, selenium 19 
supplementation combined with statins therapy was proved to be significantly beneficial to lipid 20 
therapy13 and mushrooms can be Se-fortified by addition of sodium selenite to their cultivation 21 
substrates to modify their biological properties.14 Thus, if there are statin-producer mushroom 22 
strains, they might also be Se-fortified to enhance their hypocholesterolemic effect.  23 
However, other authors found no detectable lovastatin levels but still high HMGCR 24 
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inhibition activities.6,15. Other compounds such as lanosteroids, ganoderols etc., were 1 
described in G.lucidum and apparently they were also able to inhibit the enzyme but 2 
through an indirect mechanism.6. 3 
A. bisporus basidiomata were able to lower blood glucose and cholesterol levels in diabetic 4 
and hypercholesterolemic rats and it was suggested that dietary fibers might be involved, 5 
but via a complex process.8 The mushroom dietary fiber fraction includes mainly chitins 6 
and in higher amounts -glucans. Fungal -glucans are polysaccharides of D-glucose 7 
monomers linked by β-glycosidic bonds showing preference for the -(1,3/1,6) bonds 8 
instead of the -(1,3/1,4), the characteristic pattern of cereals -glucans.16 In this study, the 9 
HMGCR inhibitory properties of A. bisporus extracts are reported as another pathway 10 
which might also contribute to the observed lowering of cholesterol levels in serum. The 11 
distribution of the potential inhibitor/s depending on the cultivation parameters, different 12 
strains (including Se-fortified strains), developmental stages etc., was also monitored. 13 
Supercritical fluid extraction (SFE) with CO2 as well as accelerated solvent extraction 14 
(ASE) are ecologically and economically sustainable processes that are increasingly being 15 
developed as a response to recent reports concerning the environmental status of our 16 
planet.17 Moreover, both methods satisfy the demand of environmentally clean extraction 17 
processes to produce new extracts or compounds with a potential use as functional 18 
ingredients or nutraceuticals. The use of supercritical carbon dioxide, with properties such 19 
as low viscosity, high solvent strength and zero surface tension has been encouraged as a 20 
substitutive of organic solvents. It has been previously used in the extraction of different 21 
compounds from mushroom strains.18-23 On the other hand, when water is used at higher 22 
temperatures and pressures (as occurring in ASE) it can also replace organic solvents. Water 23 
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can also be used in combination with ethanol, a GRAS (i.e., generally recognized as safe) 1 
solvent used in the food industry, to tailor the extract composition and therefore its 2 
beneficial properties. Accelerated solvent extraction using water has also been used to 3 
extract polysaccharides and compounds with different biological activities from L. edodes, 4 
P. ostreatus and G. lucidum.15,24-26 However, to our knowledge there are no studies on the 5 
screening of the HMGCR inhibitory properties of A. bisporus extracts produced by either 6 
SFE or ASE technologies.  7 
Therefore the other aim of this work was to compare these two extraction technologies in 8 
order to optimize methods to obtain fractions from A. bisporus with high HMGCR 9 
inhibitory activities to design novel ingredients for hypocholesterolemic functional 10 
foodstuffs. 11 
 12 
MATERIALS AND METHODS 13 
Biological Material 14 
Agaricus bisporus L. (Imbach) mushrooms were grown in cultivation rooms with automatic 15 
control of cultivation parameters (temperature, r.h., CO2) at CTICH (Centro Tecnológico de 16 
Investigación del Champiñón de La Rioja, Autol, Spain) or at the cultivation facilities of 17 
some mushroom growers belonging to the La Rioja´s mushroom association using as 18 
substrate the commonly utilized indoor compost phase II. A more detailed explanation of 19 
the experimental trials, utilized substrates, casing layers and spawns and Se 20 
supplementations can be found elsewhere.27  Basidiomata were harvested at stage 2-3 21 
according to Hammond et al.28 except in those experiments when the effect of the 22 
developmental stage was studied. The recorded parameters are described in table 1. 23 
Basiodiomata or their separate tissues (manually separated with the help of a knife) were 24 
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dehydrated (lyophilized) and ground into fine powder as described by Ramírez-Anguiano et 1 
al.29 Dried mushroom powders were stored at -20ºC until further use.  2 
A minimum of three sporophores were harvested from the same cultivation bed with 3 
identical conditions for each different type of sample.  4 
 5 
Determination of selenium  6 
The digestion procedure and hydride generation atomic absorption spectrometry (HG-AAS) 7 
method was optimized at CTICH based on previous reports.30,31 Briefly, mushroom 8 
powders (0.4 g) were introduced into a Teflon microwave digestion vessel and HNO3 7.7 F 9 
was added to an 8 mL final volume. The vessel was closed and fastened into the rotor. The 10 
rotor with 6 loaded vessels was placed into the microwave oven (Milestone Ethos Touch 11 
control). The applied microwave digestion program was as follows: 0-100ºC (3min), 12 
100-150ºC (7min), 150-180ºC (6 min) and 180ºC (15min). The digested samples were 13 
adjusted to 20 mL with HCl 4F and heated at 95ºC for 20 min to ensure reduction of Se 14 
(VI) to Se (IV). Once mixture cooled down, the mixture was diluted with 50 mL HCl 4F. 15 
Selenium was determined by HG-AAS with optimized parameters. Detection was 16 
performed by an HG-AAS system (Solaar M6 MK2 Dualz, Cambridge, UK). The peak 17 
areas of the absorbance were used for calculation of selenium content. HG-AAS technique 18 
required a selenium hollow cathode lamp to operate at a wavelength of 196.0 nm with a slit 19 
width set to 0.5 nm and an electrodeless discharge lamp set at 10 mA current without 20 
background corrector. Aspiration time was 45 s, measuring time 5 s, the height signal 21 
evaluation and argon flow 314 mL min-1. Atomizing environment was silicous cell heated 22 
to 900 °C, floated solution HCl (10 mol L-1) and reducers were 0.3% NaBH4 and 0.4% 23 
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NaOH. Selenium determination was performed in duplicate and quantified according to a 1 
Se calibration curve. 2 
 3 
Accelerated solvent extractions (ASE)  4 
Mushroom powder (1g) were mixed with washed sea sand (4 g) (Panreac, Spain) and 5 
submitted to pressurized solvent extraction using an Accelerated Solvent Extractor (Dionex 6 
Corporation, ASE 350, USA). The sea sand was selected as an inert material to hold the 7 
sample inside the extraction cell and to improve efficiency avoiding formation of 8 
preferential flow paths. Extraction procedure (per cycle) was carried out at 10.68 MPa 9 
(1500 psi) as follows: firstly, the sample was loaded into 11 ml extraction cell, then, the cell 10 
was filled with ethanol, heated-up and static extraction was carried out during the selected 11 
minutes with all system valves closed. When a cycle was finished, the cell was rinsed, the 12 
solvent was purged out of the cell with N2 gas and the cell remained depressurized. Then, 13 
fresh solvent was again added to the extraction cell to carry out another extraction cycle 14 
until the programmed number of cycles was finished. The fractions collected after the 15 
selected cycles were pooled together in a vial as a single extract. 16 
Several parameters such as solvent, static extraction time or cycles number and temperature 17 
were changed in order to optimize the extraction method to obtain fractions with high 18 
HMGCR inhibitory activity.  19 
After collection, fractions were immediately concentrated with a rotary evaporator (40ºC), 20 
frozen and lyophilized. Dried samples were stored at -18ºC until further analysis. Extracted 21 
dry matter content was measured to calculate the extraction yields. Extractions were carried 22 
out in duplicate.  23 
 24 
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Supercritical fluid extractions (SFE)  1 
Supercritical fluid extractions (pilot-plant scale) with CO2 (Air-Liquid España, S.A., 2 
Madrid, Spain) were carried out in a plant (Thar Technology, Pittsburgh, PA, USA, model 3 
SF2000) comprising a 2 L cylinder extraction cell and two different separators (S1 and S2), 4 
each of 0.5 L capacity, with independent control of temperature and pressure. The 5 
extraction vessel has a height/diameter ratio of 5.5 (0.42 m height, 0.076 m internal 6 
diameter). A detail explanation of the experimental device can be found elsewhere.32 For 7 
each experiment, the extraction cell was filled with 80 g of mushroom powder and 900 g of 8 
washed sea sand (Panreac, Spain). In order to optimize the extraction method to obtain 9 
fractions with high HMGCR inhibitory activity, parameters such as the use of a co-solvent 10 
(ethanol, 10% w/w) and extraction pressure (30, 18 and 9 MPa) were tested. Extraction 11 
temperature as well as temperature of separators 1 and 2 was set to 40ºC for all the 12 
experimental assays. Pressure of separator 1 and separator 2 using ethanol as co-solvent 13 
was maintained at 6 and 0.1 MPa respectively, however in CO2 extraction both separators 14 
were kept at a pressure of 6 MPa. The CO2 flow was set to 2.4 kg h
-1 and the total 15 
extraction time was of 3 h. For each experiment, extracts collected in separator 1 and 2 16 
were mixed together concentrated to dryness with a rotary evaporator and stored at -18oC 17 
until further analysis. Extracted dry matter content was measured to calculate the extraction 18 
yields. All the experiments were carried out in duplicate. 19 
 20 
Determination of HMGCR inhibitory activity 21 
Mushroom powders or obtained mushroom extracts (50 mg mL-1) were mixed with water 22 
(heated at 50ºC or room temperature) or with methanol:water (1:1 v/v). Suspensions were 23 
shacked in a Vortex for 1 min and centrifuged at 9659 x g for 2 min. Supernatants (20 µL) 24 
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were applied into a 96 wells-plate (Corning Incorporated Life Sciences, MA, USA) 1 
according to the user´s manual of the 3-hydroxy-3-methyl-glutaryl CoA reductase 2 
(HMGCR) Assay (Sigma, Madrid). Absorbance at 340 nm was monitored at 37ºC using a 3 
microplate reader (Tecan Group Lt, Switzerland). Determinations were carried out in 4 
duplicate.  5 
 6 
HPLC-MS/MS analysis of the extracts 7 
Mushroom extracts (3 mg mL-1) showing HMGCR inhibitory capacity were injected (20µL) 8 
into an Accela HPLC-MS/MS (Thermo Electron Corporation, San Jose, CA) equipped with 9 
an ACE 3 C18-AR column 150 x 4.6 mm, 3 μm particle size (Advanced Chromatography 10 
Technologies, Aberdeen, UK). The mobile phase was a mixture of acetonitrile: 0.5% acetic 11 
acid in water (60:40 v/v) running isocratic for 30 min. Flow rate was 0.5 mL min-1. 12 
Detection was accomplished by using photodiode array detector (200-700 nm) and a mass 13 
spectrometer (triple quadrupole) (TSQ-Quantum, Thermo Electron Corporation, San Jose, 14 
CA) with an ESI (Electrospray Ionization) interface.  15 
For mass spectrometry analysis spray voltage was set in 3500 V in positive mode, nitrogen 16 
was used as sheath gas at 350ºC and 35 arbitrary flow/pressure units. Mass analyzer was set 17 
simultaneously in full scan and SRM (Single Reaction Monitoring) modes, in this case 18 
SRM experiments were done using 1 precursor ion and 1 daughter as recommended by UE 19 
regulation (Comision Decission 657/2002 about performance of analytical methods and the 20 
interpretation of results). SRM filters were set for a better quantification of statins, 21 
precursor and product ions. Moreover, a full scan mode was used within a mass range of 22 
200-800 m/z. Statins including pravastatin, lovastatin, simvastatin and atorvastatin (Cinfa, 23 
Spain) were used as standards. Determinations were carried out in duplicate.  24 
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Determination of the HMGCR inhibitors chemical nature  1 
Agaricus bisporus dry powder (50 mg mL-1) showing HMGCR inhibitory activity was 2 
mixed with methanol:water (1:1) vigorously shacked in a Vortex for 1 min, centrifuged at 3 
9659 x g in a microfuge for 2 min and the obtained supernatant separated. Supernatant was 4 
filtrated through a 0.45 m filter and the filtrate was submitted to several filtrations using 5 
centrifugal filters (VWR, Barcelona, Spain) with cut off of 10 and 3 kDa Microcom filters 6 
(Millipore, Madrid, Spain) using a microfuge. Fractionated samples were then applied to 7 
the HMGCR activity test in order to estimate the molecular weight of the potential 8 
HMGCR inhibitors.  9 
The mushroom samples in methanol:water (1:1) were also prepared by mixing them with 10 
enzymatic preparations such as: i) a mixture of exo-1,3--glucanase (100 U ml-1) and 11 
-glucosidase (20 U ml-1), ii) a mixture of invertase (500 U ml-1) and amyloglucosidase 12 
(1630 U ml-1) and iii) pepsin (536 U ml-1). Treated samples where incubated for 1 min and 13 
centrifuged (9659 x g 2 min.). Supernatants were submitted to filtration using the 10kDa 14 
filters and the microfuge (13147 x g 30 min) in order to separate the enzymes avoiding 15 
interferences. Then, the HMGCR inhibitory activity of the separated fractions was 16 
determined.  17 
The same methanol:water extracts showing HMGCR inhibitory activity where applied to 18 
the HMGCR activity test but altering the application procedure. Usually, in this test 19 
solutions are applied following the sequence: first the buffer, then NADPH, substrate, 20 
standard inhibitor (pravastatin) as control or sample (potential inhibitory preparation) and at 21 
the end the HMGCoA reductase. Then, the test was performed by mixing the sample and 22 
substrate separately and applying the mixture when substrate should be added or mixing the 23 
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sample with the enzyme and applied at the end. Moreover, similar mixtures were also 1 
prepared and applied but mixing the sample with a diluted solution (1/2) of pravastatin or 2 
with the enzyme but in the presence of the diluted pravastatin concentration. All the 3 
experiments were carried out in duplicate. 4 
  5 
Statistical analysis  6 
One way analysis of variance (ANOVA) was performed using a Statgraphics® Plus 3.1 for 7 
Windows software (Statistical Graphics Corporation, Maryland, USA). The mean 8 
comparison test used was Fisher’s least significant differences procedure (LSD). 9 
 10 
RESULTS AND DISCUSSION 11 
Influence of the cultivation systems 12 
According to preliminary results,27,33 cultivation parameters influence the HMGCR 13 
inhibitory activity found in A. bisporus basidiomata because when different growers were 14 
cultivating the same mushroom variety, large differences in the percentage of inhibition 15 
were observed. 33 However, some of those parameters such as the casing layer utilized to 16 
induce fructification did not affect significantly the presence of HMGCR inhibitory 17 
compounds and no correlation was neither observed with other parameters such as crop 18 
quality or infections (bacterial, fungal and pests).33 Other reports also indicated that water 19 
was the best solvent to extract HMGCR inhibitors from several mushrooms except for A. 20 
bisporus which showed higher HMGCR inhibitory activity in methanol:water extracts.15 21 
Thus, A. bisporus basidiomata from the same spawn variety (Fungisem H-15) were 22 
cultivated at the same cultivation room in three different batches and harvested to 23 
investigate the variability from trial to trial and between the first three flushes. The 24 
12 
 
mushroom powders obtained from the collected basidiomata were mixed with both solvents 1 
to compare and results indicated that there were no significant differences between trials. 2 
The methanol:water extracts obtained from mushrooms harvested in the first and second 3 
flush showed a lower HMGCR inhibitory capacity (respectively 14.4 and 11.2%) than 4 
those harvested from the third flush (29.5%). Thus, the potential inhibitor/s might be 5 
compounds related to the secondary metabolism (i.e. statins) since in the third flush, 6 
mushrooms obtain less nutrients from the substrate than during the first and second flushes. 7 
On the other hand, it might also suggest that the HMGCR inhibitory activity of the 8 
basidiomata might be modulated by the presence/absence of specific compounds. 9 
Mushrooms can be Se-fortified by addition of sodium selenite to their cultivation substrates 10 
and this supplementation can modify their biological properties.14 Moreover, selenium 11 
supplementation combined with statins was proved to enhance the statin effect on the 12 
reduction of cholesterol levels.13 Thus, if these A. bisporus strains were able to produce 13 
statins or related compounds, Se-fortified mushroom strains could perhaps enhance their 14 
HMGCR inhibitory activity. Therefore, A. bisporus mushrooms (Fungisem H15) were 15 
cultivated in substrates supplemented with a low and a high dose of selenite. The selenium 16 
absorbed by the Se-fortified basidioma was also measured and the HMGCR inhibitory 17 
activity evaluated. However, no correlation was found between the selenium 18 
supplementation nor the levels of selenium absorbed by the basidioma and the inhibitory 19 
capacity. Selenium content in the basidiomata ranged from an average value of 3.2 ppm in 20 
control samples, 10.9 ppm in the lower selenium application up to 31.6 ppm in the highest 21 
applied dose and the HMGCR inhibitory activity ranged from 5.7 up to 48.9 % 22 
independently of the Se content evaluated. These inhibition values were in the range of 23 
those usually found for non Se-fortified mushrooms therefore, no synergistic effect or 24 
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enhancing of the HMGCR inhibitory activities was observed by selenium supplementation.  1 
 2 
Variability within the Agaricus bisporus commercial strains 3 
Spawns from several commercial A. bisporus varieties were cultivated and the obtained 4 
basiodiomata from the first flush harvested. Only the methanol:water (1:1 v/v) extracts 5 
obtained from Somycel A-15 showed a significantly lower HMGCR inhibitory activity 6 
compared to the others varieties (Figure 1). No differences were found between summer 7 
varieties such as Gurelan 60 and the other strains preferentially cultivated in winter. Wise 8 
to mention was the fact that water extracts obtained from Fungisem H15 also showed 9 
inhibitory capacities opposite to the rest of the varieties suggesting the presence of different 10 
inhibitory compounds within the strains.  11 
 12 
Developmental and tissue distribution of the HMGCoA-reductase inhibitors 13 
A. bisporus basidiomata (Fungisem H15 from the third flush) from the same cultivation 14 
tray were harvested at different developmental stages including from primordia until the 15 
veil was broken and the gills were visible (stage 5). However, the HMGCR inhibitory 16 
activity did not correlated to the basidioma developmental stage since primordia showed a 17 
slightly higher inhibitory activity (37.8%), stages 3 and 4 showed 30.8% inhibition and 18 
mature mushrooms (stages 5-6) an insignificant increase (32.7%). Therefore, the HMGCR 19 
inhibitory capacity was ever present through the complete sporophore life cycle.  20 
Similarly, the tissue distribution showed no preferential location of the potential inhibitor/s 21 
within the basidioma. Epidermis, dermis, gills, veil, stipe and lower part of the stipe were 22 
analyzed and only gills extracts appeared to have a slightly lower inhibitory capacity 23 
compared to the other tissues (Fig 2). These results were in disagreement9 with those of 24 
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pointing gills as the tissue with higher lovastatin concentration, indicating that perhaps this 1 
compound was not in this case the responsible for the observed HMGCR inhibitory activity. 2 
Interestingly, the lower part of the stipe, usually removed during harvesting and discarded, 3 
showed 56.9% inhibitory capacity indicating that these mushroom by-products could be 4 
valorized and utilized to extract HMGCR inhibitors. 5 
 6 
ASE extraction to obtain fractions with high HMGCR inhibitory activity 7 
A. bisporus basidiomata were submitted to extraction with pressurized solvents in order to 8 
obtain mushroom fractions with high HMGCR inhibitory activity. Two advanced extraction 9 
methodologies were tested, supercritical fluid extraction (SFE) and accelerated solvent 10 
extraction (ASE). 11 
According to recent studies15 the extraction yield of HMGCR inhibitors was highly 12 
influenced by the extraction temperature (for other mushroom species such as Pleurotus 13 
ostreatus and Lentinula edodes), while other parameters such as extraction time and cycles 14 
did not remarkably improved the extraction of the potential inhibitors. Thus, A. bisporus 15 
extractions were carried out selecting 5 cycles of 5 min (optimal conditions for the two 16 
other species) but at different temperatures and using water (as used for the other 17 
mushroom species) and a mixture of ethanol:water (1:1 v/v). The same extraction 18 
procedures were applied to two of the mushroom varieties which showed more interesting 19 
HMGCR inhibitory activities (Fungisem H15 and Gurelan 60). 20 
Increasing of temperature from 25 up to 200ºC resulted in a higher yield (higher percentage 21 
of extracted compounds) with the temperature. Similar results and extraction yields were 22 
obtained for both Gurelan 60 (ranging from 243 up to 787 mg g-1 mushroom dw) and 23 
Fungisem H15 (table 2) varieties being 200ºC the best condition to extract approx. 80 % of 24 
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the material using water as pressurized solvent. When ethanol:water (1:1) was used as 1 
extraction solvent a slightly lower yield than with plain water was obtained when the 2 
extraction was performed at 25ºC. But, increasing of temperatures resulted in increasing 3 
extraction yields up to similar percentages than using 100% water. Higher temperatures 4 
were not considered because at 150 and 200ºC, the presence of the organic solvent induced 5 
a remarkable browning in the extracts provoking color interferences when analyzing their 6 
HMGCR inhibitory activities. Moreover, the increase of temperature was detrimental for 7 
the HMGCR inhibitory capacity of the fractions suggesting that the compounds responsible 8 
for the inhibition were thermo labile (Figure 3).  9 
Water extracts obtained at room temperature (with or without pressure) did not show 10 
interesting HMGCR inhibitory activity. Temperatures higher than room temperature should 11 
be used in order to increase the extraction of the potential HMGCR inhibitor/s being the 12 
extracts obtained at 50ºC the fractions which showed higher inhibitory activities (ASE and 13 
standard extractions). However, the extractions carried out with ethanol:water as 14 
pressurized solvent showed higher HMGCR inhibitory activities than water extracts and in 15 
this case, the use of temperatures higher than 25ºC was detrimental. Standard solvent 16 
extraction using a mixture of ethanol:water at 50ºC could not be carried out because of 17 
discolouration. On the contrary than occurring in ASE extractions, the oxygen present in 18 
the solution and the organic solvent induces activation of the mushroom polyphenol 19 
oxidases34 impairing the proper determination of the HMGCR inhibitory activity.  20 
These results indicate that A. bisporus might contain compounds able to interfere with the 21 
extraction process or that the compounds responsible of the inhibitory capacity of A. 22 
bisporus extracts might be different than those extracted by ASE from P. ostreatus and L. 23 
edodes since in the latter mushrooms pressurized water was a more effective solvent to 24 
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extract fractions with high HMGCR inhibitory activities.15 1 
 2 
SFE extraction to obtain fractions with high HMGCR inhibitory activity 3 
Results obtained from the ASE experiments showed that the extraction of potential 4 
HMGCR inhibitor/s detected in A. bisporus basidioma was enhanced when using a mixture 5 
of water:organic solvent instead of plain water, indicating certain apolarity in the 6 
compounds of interest and suggesting that they might also be susceptible of SFE extraction. 7 
Then, A. bisporus basidiomata were submitted to extraction with pressurized CO2 and CO2 8 
combined with 10% ethanol as modifier. Results showed that the highest extraction yields 9 
were obtained when ethanol was added to the CO2 but higher extraction pressure did not 10 
significantly increased the extraction yield (Table 3). In terms of HMGCR inhibition, 11 
fractions obtained with the help of ethanol and at 9 MPa showed a slightly higher inhibitory 12 
activity than those obtained at lower pressures (Figure 4). However, no significant 13 
differences were found in samples extracted without modifier indicating that the fractions 14 
obtained with ethanol and low pressure were more selective to isolate the potential 15 
HMGCR inhibitor/s. These results can be explained in terms of CO2 density: at higher 16 
pressures the density –and hence the extracting power- of supercritical CO2 increases at 17 
constant temperature, so higher extraction yields were expected when working at 30 MPa. 18 
Nevertheless, the higher number of compounds present in the fractions obtained at higher 19 
pressures could have caused a dilution effect on the compounds responsible of the HMGCR 20 
inhibition leading to better results in fractions recovered under lower extraction pressures (9 21 
MPa). 22 
Since it was previously indicated that the lower part of the A. bisporus stipes (which are 23 
usually discarded) showed interesting HMGCR inhibitory activities, SFE extractions were 24 
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also performed using these by-products. Extractions carried out at 30 MPa with ethanol as 1 
co-solvent showed 82.74 % inhibition, 2 fold higher inhibitory activity than the same SFE 2 
extract obtained from the basidioma, pointing these by-products as an interesting source of 3 
HMGCR inhibitor/s. 4 
However, direct extractions with methanol:water (1:1) from the powdered by-product 5 
applied at the same concentration than the SFE extract showed already 56.9% inhibition 6 
and 80 g of mushroom powder were necessary to obtain 1.42 g SFE extract with only 1.5 7 
fold higher activity than the mushroom powder thus, SFE was not a method highly 8 
selective to obtain fractions with high HMGCR inhibitory activity. On the contrary, ASE 9 
extractions at 25ºC showed 1.6 fold higher inhibitory activity than direct extraction when 10 
the same amount of starting material (1g) was used. Thus, the latter method was more 11 
suitable than SFE for potential HMGCR inhibitor/s extraction. 12 
 13 
Presence of statins in the Agaricus bisporus extracts 14 
A. bisporus extracts with HMGCR inhibitory activity were injected in an LC-MS/MS 15 
system to investigate whether the observed inhibition was due to the presence of statins as 16 
it was described by other authors10,11 since they also observed higher inhibitory capacity in 17 
samples obtained with methanol:water rather than with water.9 However, no detectable peak 18 
at the retention time of pravastatin (3.82 min), atorvastatin (8.06 min), simvastatin (9.83 19 
min) or lovastatin (20.26 min) was observed.  20 
Agaricus bisporus extracts showed three peaks at 4.8, 8.8 and 13.2 min with 567, 459 and 21 
520 m/z different from those of the utilized standard statins (Table 4). The statins SRM 22 
transitions were similar to those used previously by other authors,35 therefore, statins were 23 
not in this case responsible for the observed HMGCR inhibitory activity.  24 
18 
 
 1 
 2 
Determination of the HMGCR inhibitors chemical nature 3 
Since statins were not present in the Agaricus bisporus extracts showing HMGCR 4 
inhibitory activity, a preliminary attempt to identify the nature of the inhibitors was carried 5 
out. Thus, the methanol:water extracts (showing 47.2% inhibitory activity) were 6 
fractionated by molecular weight using specific filtering devices with cut off of 10 and 3 7 
kDa. The obtained fraction including compounds with a molecular weight higher than 10 8 
kDa showed 61.5 % inhibitory activity. However, the fraction with molecular weight lower 9 
than 10 kDa also showed high inhibitory capacity (50.4 %). Thus, the latter fraction was 10 
further fractionated using a 3kDa filter and the higher inhibitory activity was found in the 11 
fraction with a molecular weight between 10 and 3kDa (44.2 %) being lower than 23% in 12 
the filtrate corresponding to the low molecular weight fraction. Results indicated that the 13 
potential HMGCR inhibitors might be molecules of high molecular weight, higher than 10 14 
kDa. However, the fact that the fractions with molecular weight higher than 3 kDa also 15 
showed interesting inhibitory activity could indicate on the one hand, that the possible 16 
degradation products obtained from the molecules with molecular weight higher than 10 17 
kDa might still acts as inhibitors or on the other hand, that the inhibitors were not a single 18 
compound but molecules with a wide range of molecular weights. In both cases, results 19 
suggested that the inhibitor/s were macromolecules, thus, they could be proteins or 20 
polysaccharides (or a mixture of both type of structures, proteoglucans etc.). 21 
Therefore, in order to define furthermore the chemical nature of the inhibitors, the 22 
mushroom extracts showing HMGCR inhibitory activities were treated with specific 23 
enzymes mixtures. When pepsin was applied to the mushroom extract only a slight 24 
19 
 
reduction of the initial inhibitory capacity was observed (from 48 to 41% inhibition). The 1 
mushroom extracts mixed with enzymes able to hydrolyze -linked glucans 2 
(exo-1,3--glucanase and -glucosidase) showed only a 24.3% of HMGCR inhibition 3 
indicating that almost half of the inhibitory capacity was lost in the presence of 4 
-hydrolytic enzymes. When the extract was mixed with amyloglucosidase (hydrolyze 5 
-linked polysaccharides) and invertase still 34.1% inhibitory activity was observed 6 
indicating that -glucans (such as starch or glycogen) might not be so much involved in the 7 
inhibitory effect as -glucans.  8 
 9 
Study of the potential in vitro mechanism of action of the HMGCR inhibitors 10 
If, as above suggested, certain -glucans might be the compounds responsible of the 11 
observed inhibition, their mechanism of action cannot be similar to statins. The latter are 12 
small molecules acting as competitive inhibitors for which the enzyme showed 1000 folds 13 
more affinity (KI≈nM) than for its substrate (KM≈µM) HMGCoA 14 
(3-hydroxy-3-methulglutaryl-CoA).12 However, fungal -glucans showed gel forming 15 
properties able to scavenge small molecules within their complex structures26 thus, perhaps 16 
these water/methanol-soluble mushroom -glucans might be able to inhibit the enzyme by 17 
scavenging its substrate. Moreover, these polysaccharides can also bind proteins and if they 18 
form linkages close to the catalytic center they might also impair the enzymatic reaction. 19 
Thus, the HMGCR inhibitory test was carried out by mixing firstly the mushroom extract 20 
with the substrate or with the enzyme and then performing the standard procedure. As 21 
expected, addition of the mushroom extract inhibited the activity however, no significant 22 
differences were found if the sample was firstly mixed with the substrate or with the 23 
20 
 
enzyme. Thus, the same procedure was carried out by mixing the samples first with 1 
pravastatin instead of the substrate and with the enzyme in the presence of pravastatin. The 2 
selected statin dilution was able to inhibit 87.8% of the HMGCR activity however, if the 3 
pravastatin was mixed with the mushroom extract and added to the test 71.5% inhibition 4 
was recorded suggesting that pravastatin might have been partially scavenged because of 5 
the decrease (approx. 16%) of its inhibitory effect. But, when the sample was firstly mixed 6 
with the enzyme also 11% reduction in the pravastatin inhibitory activity was observed 7 
suggesting that the sample was also impairing the proper binding of the inhibitor into the 8 
catalytic site (since the enzyme has more affinity for pravastatin than for the substrate).  9 
Results indicated that both proposed mechanisms could be possible and might take place 10 
simultaneously at least in the well of the in vitro test since the same mushroom extract was 11 
acting as HMGCR inhibitor or as inhibitor of the pravastatin inhibitory action depending on 12 
the testing conditions. However, in order to test whether these mechanisms have a real 13 
significance in vivo, animal models should be utilized. Morevoer, it is wise to mention that 14 
not all the -glucans present in A. bisporus were able to inhibit the HMGCR activity since 15 
for instance the ASE extracts obtained using pressurized water at 150ºC (Figure 3) 16 
contained large amounts of -glucans26 but they showed very low HMGCR inhibitory 17 
activity.   18 
      19 
CONCLUSIONS 20 
Agaricus bisporus extracts able to inhibit the 3-hydroxy-3-methyl-glutaryl CoA reductase 21 
(HMGCR) activity could be obtained by environmentally friendly advanced technologies 22 
such as supercritical fluid extractions (SFE) with CO2 and 10% ethanol and accelerated 23 
21 
 
solvent extractions (ASE) using methanol:water (1:1 v/v) as pressurized solvent being the 1 
latter more effective than SFE or standard extraction methods. Cultivation parameters, flush, 2 
strain and tissue type could modulate the higher or lower HMGCR inhibitory activity but 3 
not the substrate supplementation with selenium. LC-MS analysis confirmed the absence of 4 
statins in the inhibitory fractions obtained instead, certain -glucans easily extracted with 5 
methanol:water at moderated temperatures (lower than 100ºC) and with molecular weight 6 
higher than 10 kDa., were pointed as the compounds which might be responsible the 7 
observed activity. They might scavenge the HMGCR substrate and bind to the enzyme 8 
impairing the enzymatic reaction in the in vitro HMGCR activity test.  9 
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Table 1. Cultivation parameters recorded and correlated with the HMGCR inhibitory 4 
activity values obtained within the analyzed A. bisporus samples. 5 
 6 
Parameter Different type of samples 
Selenium-enriched mushrooms Low (10.9 ppm)/ high (31.6 ppm)/ control (3.2 ppm) Se 
content 
Commercial spawn Fungisem H15 and H5,Gurelan 60, Mispaj 365 and 
Somycel A15 
Developmental stage Primordia(stage 1), small(2), medium(3-4), large(5-6) 
Flush number First, second and third flush 
 7 
8 
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Table 2. Extraction yields obtained after submission of Agaricus bisporus (Fungisem H15) 1 
basidiomata to ASE at different temperatures using two different pressurized solvent 2 
mixtures. 3 
 4 
ASE 
temperatures  
100% water Ethanol:water (1:1) 
(ºC)  (mg g-1 dw)         %  (mg g-1 dw)         % 
 
    
25 185±94.75a 18.5 62±13.11a 6.2 
50 261±127.99a 26.1 181±29.70b 18.1 
100 283±70.71a 28.3 333±25.71c 33.3 
150 484±44.55b 48.4 NC - 
200 749±156.98c 74.9 NC - 
NC: not considered 5 
a,b,c Denotes statistically significant differences (P < 0.05) among values from the same 6 
column 7 
 8 
9 
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Table 3. Extraction yields obtained after submission of Agaricus bisporus (Fungisem H15) 1 
basidioma to SFE at different pressures with or without ethanol as co-solvent. 2 
 3 
a,b Denotes statistically significant differences (P < 0.05) among values from the same 4 
column 5 
  6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
SFE 
pressures 
With 10% ethanol Without 10% ethanol 
(MPa) Extracted weight (g) % Extracted weight (g) % 
     
9 1.24±0.1a 1.55 0.50±0.13a 0.62 
18 1.36±0.22a 1.70 0.60±0.20a 0.75 
30 1.50±0.31a 2.08 0.56±0.16a 0.70 
30 
 
 1 
Table 4: SRM transitions and energies used for statins analysis. 2 
 3 
Compound Parent ion (m/z) Product ion (m/z) Collision Energy (V) 
Lovastatin 427.101 M+Na+ 324.921 24 
Simvastatin 441.106 M+Na+ 324.812 24 
Pravastatin 447.099 M+Na+ 326.924 18 
Atorvastatin 559.114 M+H+ 439.998 24 
 4 
 5 
 6 
  7 
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 1 
Figure 1. HMGCR inhibitory activity of A. bisporus extracts obtained from different 2 
commercial varieties. 3 
a,b Denotes statistically significant differences (P<0.05) among the values from the same 4 
extraction solvent. 5 
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 1 
Figure 2. Tissue distribution of the HMGCR inhibitory activity observed within the A. 2 
biporus basidioma. The dotted line delimitate the tissues which are usually commercialized 3 
(above the line) or discarded during the harvesting (lower part of the stipe and mycelium).  4 
a,b,c Denotes statistically significant differences (P<0.05) among the values. 5 
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Figure 3. HMGCR inhibitory activity of the ASE fractions obtained using two pressurized 2 
solvents at different temperatures from A. bisporus (Fungisem H15) compared with 3 
standardized solid:liquid extractions. 4 
a,b Denotes statistically significant differences (P<0.05) among the values from the same 5 
extraction solvent. 6 
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 2 
Figure 4. HMGCR inhibitory activity of the SFE fractions obtained using different 3 
pressures with or without ethanol as modifier from A. bisporus (Fungisem H15). 4 
a,b,c Denotes statistically significant differences (P<0.05) among the values from the same 5 
extraction solvent. 6 
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